About Von Willebrand Disease — What is VWD
The Humate-P® Difference: High Quality & Quantity
Home Infusion Video
Mix2Vial™ Needle-Free transfer Device
The CSL Behring Commitment
Resources and Tools
News & Events
Important Safety Information
Prescribing Information
Request More Information
For Healthcare Professionals
      

The CSL Behring Commitment

CSL Behring offers many programs and services to the bleeding disorders community, in addition to its range of blood products. Check out this wide variety of resources:

Reimbursement Resources Center
Call 1-800-676-4266 for expert advice and information about insurance matters, including health insurance reimbursement for CSL Behring products.

Patient Assistance Program
This program provides medically necessary therapies to qualified patients who are uninsured, underinsured, or who cannot afford their prescribed therapy.

CSL Behring AssuranceSM
A lapse in insurance coverage can happen—and it can be scary. CSL Behring AssuranceSM helps people who rely on Humate-P® to continue to receive treatment during a lapse in third-party private health insurance.

Project Red Flag
Project Red Flag (PRF) is a campaign by the National Hemophilia Foundation aimed at educating women and their healthcare providers about the symptoms, diagnosis, and treatment of bleeding disorders.CSL Behring proudly supports PRF, along with the Centers for Disease Control and Prevention.

Gettin’ in the Game SM
Gettin’ in the Game was started by CSL Behring to encourage kids with bleeding disorders to be physically active. Children and their families can get sports tips from professional athletes, participate in exercises or sports competitions, and meet other kids with bleeding disorders.

VWD Consumer Advisory Committee
CSL Behring hosts meetings with VWD patients and parents to keep current on the needs and interests of the VWD community, and to provide a forum for consumers to exchange ideas.

CSL Behring Junior National Championships
A fun-filled annual golf and baseball competition for children ages 7 through 18.

For more information about programs and services offered by CSL Behring, call our Consumer Affairs Center at 1-888-508-6978.


Important Safety Information

Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized, Humate-P® is indicated in adult patients for treatment and prevention of bleeding in hemophilia A (classical hemophilia). Humate-P® is also indicated in adult and pediatric patients with von Willebrand disease (VWD) for (1) treatment of spontaneous and trauma-induced bleeding episodes, and (2) prevention of excessive bleeding during and after surgery. This applies to patients with severe VWD, and patients with mild and moderate VWD for whom use of desmopressin is known or suspected to be inadequate.

Humate-P® is contraindicated in individuals with a history of anaphylactic or severe systemic response to antihemophilic factor or von Willebrand factor preparations or to any of its components.

Thromboembolic events have been reported in VWD patients receiving coagulation factor replacement, especially in the setting of known risk factors for thrombosis. Caution should be exercised and antithrombotic measures considered.

Humate-P® is derived from human plasma. As with all plasma-derived products, the risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be completely eliminated.

Although few adverse reactions have been reported the most common are allergic-anaphylactic reactions, including urticaria, chest tightness, rash, pruritus, edema, shock, chills and fever, and hypervolemia. For patients undergoing surgery, the most common adverse reactions are postoperative wound or injection-site bleeding.

Please see accompanying full prescribing information for Humate-P®.